About OmniaBio:
OmniaBio Inc, a subsidiary of Toronto-based CCRM, is a contract development and manufacturing organization (CDMO) producing gene-modified cell therapies and viral vectors, compliant with cGMP standards.
The facility has support from the Government of Ontario, via the Invest Ontario Fund, and is the first project to be funded through the Life Sciences Strategy. The facility will be built in phases with the ultimate goal of building the largest facility of its kind in Canada (over 350,000 sq ft). OmniaBio is Canada's first commercial-scale CDMO dedicated to cell and gene therapies.
Located on the biomanufacturing campus at McMaster Innovation Park (Hamilton, ON), OmniaBio will catalyze life sciences careers and innovation in Canada while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson's, and diabetes, amongst others. OmniaBio will support a broad range of cell and gene therapy companies globally, enabling pivotal/Phase III and commercial-scale manufacturing. OmniaBio will complete CCRM's continuum of process development, clinical and commercial capabilities. CCRM is a leader in developing and commercializing regenerative medicine-based technologies, and cell and gene therapies.
Role Summary:
OmniaBio, Inc. is looking for a BD Associate with strong experience in prospecting, lead generation, and qualification in the biopharmaceutical CDMO / industry. The Associate will be responsible for developing the early-stage cell and gene therapy customer pipeline for OmniaBio's process development and good manufacturing practices (GMP) manufacturing services and for supporting the BD team in pipeline development and expansion activities. You will work closely with technical experts across OmniaBio and its parent company, CCRM and report to the Director, Business Development.
Responsibilities:
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.